Discovery of high affinity bombesin receptor subtype 3 agonists

Molecular Pharmacology

Volumn 50, Issue 5, 1996, Pages 1355-1363

  Wu, James ^a   Nitecki, Danute E ^a   Biancalana, Sara ^a   Feldman, Richard I ^a  

^a BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOMBESIN DERIVATIVE; BOMBESIN RECEPTOR; BOMBESIN[9-13][6 DEXTRO PHENYLALANINE 13 PHENYLALANINE] PROPYLAMIDE; BOMBESIN[9-13][6 DEXTRO PHENYLALANINE] PROPYL AMIDE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DRUG POTENCY; DRUG RECEPTOR BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SEQUENCE HOMOLOGY; XENOPUS LAEVIS;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CLONING, MOLECULAR; DNA, COMPLEMENTARY; GASTRIN-RELEASING PEPTIDE; HUMANS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEUROKININ B; PEPTIDES; RECEPTORS, BOMBESIN; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION; XENOPUS LAEVIS;

EID: 0029807965     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Fathi, Z., M. H. Corjay, H. Shapira, E. Wada, R. Benya, R. Jensen, J. Viallet, E. A. Sausville, and J. F. Battey. BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. J. Biol. Chem. 268:5979-5984 (1993).
2. Gorbulev, V., A. Akhundova, H. Buchner, and F. Fahrenholz. Molecular cloning of a new bombesin receptor subtype expressed in uterus during pregnancy. Eur. J. Biochem. 208:405-410 (1992).
3. Corjay, M. H., D. J. Dobrzanski, J. M. Way, J. Viallet, H. Shapira, P. Worland, E. A. Sausville, and J. F. Battey. Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. J. Biol. Chem. 266:18771-18779 (1991).
4. Anastasi, A., V. Erspamer, and M. Bucci. Isolation and amino acid sequences of alytesin and bombesin, two analogous active tetradecapeptides from the skin of European discoglossid frogs. Arch. Biochem. Biophys. 148:443-461 (1972).
5. Erspamer, V. Discovery, isolation, and characterization of bombesin-like peptides. Ann. N. Y. Acad. Sci. 547:3-9 (1988).
6. Lebacq-Verheyden, A. M., A. M. Trepel, E. A. Sausville, and J. F. Battey. Bombesin and gastrin releasing peptide: neuropeptides, secretagogues, and growth factors. Handb. Exp. Pharmacol. 95:71-124 (1990).
7. Carney, D. N., P. Cuttitta, T. W. Moody, and J. D. Minna. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide. Cancer Res. 47:821-825 (1987).
8. Cuttitta, F., D. N. Carney, J. Mulshine, T. W. Moody, J. Fedorko, A. Fischler, and J. D. Minna. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature (Lond.) 316:823-826 (1985).
9. Nelson, J., M. Donnelly, B. Walker, J. Gray, C. Shaw, and R. F. Murphy. Bombesin stimulates proliferation of human breast cancer cells in culture. Br. J. Cancer 63:933-936 (1991).
10. Narayan, S., E. R. Spindel, N. H. Rubin, and P. Singh. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects. Cell Growth Differ. 3:111-118 (1992).
11. Bologna, M., C. Festuccia, P. Muzi, L. Biordi, and M. Ciomei. Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer 63: 1714-1720 (1989).
12. Szepeshazi, K., A, V. Schally, R. Z. Cai, S. Radulovic, S. Milovanovic, and B. Szoke. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters. Cancer Res. 51:5980-5986 (1991).
13. DeMichele, M. A., A. L. Davis, J. D. Hunt, R. J. Landreneau, and J. M. Siegfried. Expression of mRNA for three bombesin receptor subtypes in human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 11:66-74 (1994).
14. Gorbulev, V., A. Akhundova, K. H. Grzeschik, and F. Fahrenholz. Organization and chromosomal localization of the gene for the human bombesin receptor subtype expressed in pregnant uterus. FEBS Lett. 340:260-264 (1994).
15. Feldman, R. I., M. F. Bartholdi, and J. M. Wu. Bombesin-like peptide receptor subtypes promote mitogenesis, which requires persistent receptor signaling, Mol. Pharmacol. 50:1346-1354 (1996).
16. Wu, J. M., D. O. Hoang, and R. I. Feldman. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs. Mol. Pharmacol. 47:871-881 (1995).
17. Yee, J., and N. V. Christou. Neutophil priming by lipopolysaccharide involves heterogeneity in calcium-mediated signal transduction - studies using Fluo-3 and flow cytometry. J. Immunol. 150:1988-1997 (1993).
18. Heimbrook, D. C., W. S. Saari, N. L. Balishin, T. W. Fisher, A. Friedman, D. M. Kiefer, N. S. Rotberg, J. W. Wallen, and A. Oliff. Gastrin releasing peptide antagonists with improved potency and stability. J. Med. Chem. 34:2102-2107 (1991).
19. Coy, D. H., R. T. Jensen, N. Y. Jiang, J. T. Lin, A. E. Bogden, and J. P. Moreau. Systematic development of bombesin/gastrin-releasing peptide antagonists. Monogr. Natl. Cancer Inst. 13:133-139 (1992).
20. Wang, L. H., D. H. Coy, J. E. Taylor, N. Y. Jiang, J. P. Moreau, S. C. Huang, H. Frucht, B. M. Haffar, and R. T. Jensen. des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists. J. Biol. Chem. 265: 15695-56703 (1990).
21. Best, J. R., R. Camble, R. Cotton, A. S. Dutta, B. Fleming, A. Garner, J. J. Gormley, C. F. Hayward, P. F. McLachlan, and P. B. Scholes. Design and synthesis of bombesin/gastrin-releasing peptide antagonists. Biochem. Soc. Trans. 18:1294-1296 (1990).
22. Coy, D. H., J. E. Taylor, N. Y. Jiang, S. H. Kim, L. H. Wang, S. C. Huang, J. P. Moreau, J. D. Gardner, and R. T. Jensen. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity. J. Biol. Chem. 264:14691-14697 (1989).
23. Leban, J. J., A. Landavazo, J. D. McDermed, E. J. Diliberto, Jr., M. Jansen, B. Stockstill, and F. C. Kull, Jr. Potent gastrin-releasing peptide (GRP) antagonists derived from GRP (19-27) with a C-terminal DPro psi [CH2NH]Phe-NH2 and N-terminal aromatic residues. J. Med. Chem. 37: 439-445 (1994).
24. Wang, L. H., J. F. Battey, E. Wada, J. T. Lin, S. Mantey, D. H. Coy, and R. T. Jensen. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides. Biochem. J. 286:641-648 (1992).
25. Lin, J. T., D. H. Coy, S. A. Mantey, and H. T. Jensen. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes. J. Pharmacol. Exp. Ther. 276:285-295 (1995).
26. Buchan, A. M., M. Meloche, and D. H. Coy. Inhibition of bombesin-stimulated gastrin release from isolated human G cells by bombesin analogs. Pharmacology 41:237-245 (1990).
27. Wang, L. H., D. H. Coy, J. E. Taylor, N. Y. Jiang, S. H. Kim, J. P. Moreau, S. C. Huang, S. A. Mantey, H. Frucht, and R. T. Jensen. Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells. Biochemistry 29:616-622 (1990).
28. Best, J. R., R. Cotton, A. S. Dutta, B. Fleming, A. Garner, J. J. Gormley, C. F. Hayward, P. F. McLachlan, and P. B. Scholes. Antagonists of bombesin/gastrin releasing peptide based on [D-Ala24]GRP(20-26)-heptapeptide. Modifications leading to potent analogues with prolonged duration of action. Drug Des. Dev. 6:255-271 (1990).
29. Coy, D. H., Z. Mungan, W. J. Rossowaki, B. L. Cheng, J. T. Lin, J. E. Mrozinski, Jr., and R. T. Jensen. Development of a potent bombesin receptor antagonist with prolonged in vivo inhibitory activity on bombesin-stimulated amylase and protein release in the rat. Peptides 13:775-781 (1992).
30. Coy, D. H., P. Heinz Erian, N. Y. Jiang, Y. Sasaki, J. Taylor, J. P. Moreau, W. T. Wolfrey, J. D. Gardner, and R. T. Jensen. Probing peptide backbone function in bombesin. A reduced peptide bond analogue with potent and specific receptor antagonist activity. J. Biol. Chem. 263:5056-5060 (1988).
31. Leban, J. J., A. Landavazo, J. D. McDermed, E. J. Diliberto, Jr., M. Jansen, B. Stockstill, and F. C. Kull, Jr. Potent gastrin-releasing peptide (GRP) antagonists derived from GRP (19-27) with a C-terminal D-Pro psi [CH2NH]Phe-NH2 and N-terminal aromatic residues. J. Med. Chem. 37: 439-45.
32. Heimbrook, D. C., M. E. Boyer, V. M. Garsky, N. L. Balishin, D. M. Kiefer, A. Oliff, and M. W. Riemen. Minimal ligand analysis of gastrin releasing peptide. J. Biol. Chem. 262:7016-7019 (1988).
33. Seva, C., C. J. Dickinson, and T. Yamada. Growth-promoting effects of glycine-extended progastrin. Science (Washington D. C.) 265:410-412 (1994).